Effects of a catechol-O-methyltransferase inhibitor on catechol estrogen-induced cellular transformation, chromosome aberrations and apoptosis in Syrian hamster embryo cells

International Journal of Cancer

Volumn 120, Issue 8, 2007, Pages 1627-1633

  Hirose, Yutaka ^a   Tsutsui, Takeo W ^a   Ohno, Maki ^a   Barrett, J Carl ^b   Tsutsui, Takeki ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Catechol O methyltransferase; Cathecol estrogen; Cellular transformation; Chromosome aberrations

Indexed keywords

2 HYDROXYESTRONE; 2 METHOXYESTRONE; 2' FLUORO 3,4 DIHYDROXY 5 NITROBENZOPHENONE; 4 HYDROXYESTRONE; CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYRIAN HAMSTER;

ANIMALS; APOPTOSIS; BENZOPHENONES; CATECHOL O-METHYLTRANSFERASE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CRICETINAE; HYDROXYESTRONES; MESOCRICETUS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33947120245     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22398     Document Type: Article

References (36)

1. IARC. Sex hormones (II). IARC monogr 1979;21:139-362.
2. Barrett JC, Huff J. Cellular and molecular mechanisms of chemically induced carcinogenesis. Ren Fail 1991;13:211-25.
3. Tsutsui T, Barrett JC. Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals. Environ Health Perspect I997;105:619-24.
4. Tsutsui T, Suzuki N, Fukuda S, Sato M, Maizumi H, McLachlan JA, Barrett JC. 17β-Estradiol-induced cell transformation and aneuploidy of Syrian hamster embryo cells in culture. Carcinogenesis 1987;8: 1715-9.
5. Tsutsui T, Tamura Y, Yagi E, Barrett JC. Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17β-estradiol and eight of its metabolites. Int J Cancer 2000;86:8-14.
6. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspective. Carcinogenesis l998;19:1-27.
7. Liehr JG, Fang W-F, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986;24:353-6.
8. Li JJ, Li SA. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 1987;46:1858-63.
9. Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000;60:235-7.
10. Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol 1996;9:851-9.
11. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbothan S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997;94:10937-42.
12. Russo J, Lareef MH, Balogh G, Guo S, Russo IH. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem MoI Biol 2003;87:1-25.
13. Turan VK, Sanchez RI, Li JJ, Li SA, Reuhl KR, Thomas PE, Conney AH, Gallo MA, Kauffman FC, Mesia-Vela S. The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17β-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16α-hydroxyestradiol, and 4-hydroxyestrone. J Endocrinol 2004;183:91-9.
14. El-Bayoumy K, Ji B-Y, Upadhyaya P, Chae Y-H, Kurtzke C, Rivenson A, Reddy BS, Amin S, Hecht SS. Lack of tumorigenicity of cholesterol epoxides and estrone-3,4-quinone in the rat mammary gland. Cancer Res 1996;56:1970-3.
15. Barrett JC, Bias NE, Ts'o POP. A mammalian cellular system for the concomitant study of neoplastic transformation and somatic mutation. Mutat Res 1978;50:121-36.
16. Yagi E, Barrett JC, Tsutsui T. The ability of four catechol estrogens of 17β-estradiol and estrone to induce DNA adducts in Syrian hamster embryo cells. Carcinogenesis 2001;22:1505-10.
17. Zhu BT, Liehr JG. Inhibition of the catechol-O-methyltransferase- catalyzed O-methylation of 2- and 4-hydroxyestradiol by catecholamine: implications for the mechanism of estrogen-induced carcinogenesis. Arch Biochem Biophys 1993;304:248-56.
18. Goodman JE, Jensen LT, He P, Yager JD. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics 2002;12:517-28.
19. Lavigne JA, Helzlsouer KJ, Huang H-Y, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997;57:5493-7.
20. Dawling S, Roodi N, Mernaugh RL, Wang X, Pari FF. Catechol-O- methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 2001; 61:6716-22.
21. Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW, Yager JD. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res 2001;61:7488-94.
22. Barrett JC, Ts'o POP. Evidence for the progressive nature of neoplastic transformation in vitro. Proc Natl Acad Sci USA 1978;75:3761-5.
23. Miyachi T, Tsutsui T. Ability of 13 chemical agents used in dental practice to induce sister chromatid exchanges in Syrian hamster embryo cells. Odontology 2005;93:24-9.
24. Tsutsui T, Barrett JC. Detection of non-mutagenic carcinogens using cultured Syrian hamster embryo cells. Altern Anim Test Exp 1991;1: 65-73.
25. INK4a and pRb inactivation with immortalization of human cells. Carcinogenesis 2002;23: 2111-7.
26. Tsutsui T, Tamura Y, Yagi E, Sorneya H, Hori I, Metzler M, Barrett JC. Cell-transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells. Int J Cancer 2003;105:312-20.
27. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
28. Wood DE, Thomas A, Devi LA, Berman Y, Beavis RC, Reed JC, Newcomb EW. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 1998;17:1069-78.
29. Kluck RM, Bossy-Wetzel E, Green RD, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
30. Hall JM, McDonnell DP. The estrogen receptor β-isoform (ERβ) of the human receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999;140:5566-78.
31. Zhu BT, Liehr JG. Inhibition of catechol O-methyltransferase- catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin: possible role in estradiol-induced tumorigenesis. J Biol Chem 1996;271:1357-63.
32. Hurh Y-J, Chen Z-H, Na H-Y, Han S-Y, Surh Y-J. 2-Hydroxyestradiol induces oxidative DNA damage and apoptosis in human mammary epithelial cells. J Toxicol Environ Health A 2004;67:1939-4.
33. Chen Y, Liu X, Pisha E, Constantinou AI, Hua Y, Shen L, van Breemen RB, Elguindi EC, Blood SY, Zhang F, Bolton JL. A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines. Chem Res Toxicol 2000;13:342-50.
34. L during apoptosis. Proc Natl Acad Sci USA 1997; 94:3668-72.
35. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B, Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 1998;391:496-9.
36. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996;6: 243-50.